Policy Brief
⭐ 4.3
Carbon Markets for Pharmaceutical Firms: Roi And Performance Metrics | 2024–2026 Trends
Abstract
This policy brief investigates “Carbon Markets for Pharmaceutical Firms: Roi And Performance Metrics | 2024–2026 Trends” using a Delphi study. Through a institutional lens, the analysis integrates multi-source data to derive a stakeholder-aligned blueprint for researchers and practitioners.